{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:55:52Z","timestamp":1771059352468,"version":"3.50.1"},"reference-count":69,"publisher":"American Society of Hematology","issue":"8","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>This works defines, to the best of our knowledge, for the first time a molecular circuit connecting nicotinamide mononucleoside phosphoribosyl transferase (NAMPT) activity to the B-cell receptor (BCR) pathway. Using 4 distinct xenograft models derived from patients with Richter syndrome (RS-PDX), we show that BCR cross-linking results in transcriptional activation of the nicotinamide adenine dinucleotide (NAD) biosynthetic enzyme NAMPT, with increased protein expression, in turn, positively affecting global cellular NAD levels and sirtuins activity. NAMPT blockade, by using the novel OT-82 inhibitor in combination with either BTK or PI3K inhibitors (BTKi or PI3Ki), induces rapid and potent apoptotic responses in all 4 models, independently of their mutational profile and the expression of the other NAD biosynthetic enzymes, including nicotinate phosphoribosyltransferase. The connecting link in the circuit is represented by AKT that is both tyrosine- and serine-phosphorylated by PI3K and deacetylated by sirtuin 1 and 2 to obtain full kinase activation. Acetylation (ie, inhibition) of AKT after OT-82 administration was shown by 2-dimensional gel electrophoresis and immunoprecipitation. Consistently, pharmacological inhibition or silencing of sirtuin 1 and 2 impairs AKT activation and induces apoptosis of RS cells in combination with PI3Ki or BTKi. Lastly, treatment of RS-PDX mice with the combination of PI3Ki and OT-82 results in significant inhibition of tumor growth, with evidence of in\u00a0vivo activation of apoptosis. Collectively, these data highlight a novel application for NAMPT inhibitors in combination with BTKi or PI3Ki in aggressive lymphomas.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011690","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T20:54:06Z","timestamp":1708030446000},"page":"1920-1933","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["A molecular circuit linking the BCR to the NAD biosynthetic enzyme NAMPT is an actionable target in Richter syndrome"],"prefix":"10.1182","volume":"8","author":[{"given":"Vincenzo G.","family":"Messana","sequence":"first","affiliation":[{"name":"1Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Fasc\u00ec","sequence":"additional","affiliation":[{"name":"1Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Vitale","sequence":"additional","affiliation":[{"name":"2Department of Molecular Biotechnologies and Health Science, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Micillo","sequence":"additional","affiliation":[{"name":"1Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3260-4955","authenticated-orcid":false,"given":"Matteo","family":"Rovere","sequence":"additional","affiliation":[{"name":"1Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5836-8575","authenticated-orcid":false,"given":"Noemi A.","family":"Pesce","sequence":"additional","affiliation":[{"name":"1Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-7174","authenticated-orcid":false,"given":"Claudio","family":"Martines","sequence":"additional","affiliation":[{"name":"3Molecular Hematology Unit, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9081-5462","authenticated-orcid":false,"given":"Dimitar G.","family":"Efremov","sequence":"additional","affiliation":[{"name":"3Molecular Hematology Unit, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Vaisitti","sequence":"additional","affiliation":[{"name":"1Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-5036","authenticated-orcid":false,"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[{"name":"1Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"issue":"2","key":"2024042219003900500_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.seminoncol.2016.02.012","article-title":"Richter syndrome: pathogenesis and management","volume":"43","author":"Rossi","year":"2016","journal-title":"Semin Oncol"},{"issue":"25","key":"2024042219003900500_bib2","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2018-01-791376","article-title":"Biology and treatment of Richter syndrome","volume":"131","author":"Rossi","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2024042219003900500_bib3","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"10","key":"2024042219003900500_bib4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter\u2019s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"15","key":"2024042219003900500_bib5","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"issue":"20","key":"2024042219003900500_bib6","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.2020005650","article-title":"Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia","volume":"137","author":"Klintman","year":"2021","journal-title":"Blood"},{"issue":"3","key":"2024042219003900500_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11912-020-01001-x","article-title":"Richter syndrome","volume":"23","author":"Condoluci","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"2024042219003900500_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41375-018-0303-x","article-title":"The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia","volume":"33","author":"Ten Hacken","year":"2019","journal-title":"Leukemia"},{"issue":"23","key":"2024042219003900500_bib9","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1182\/blood-2014-09-603217","article-title":"Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8","volume":"125","author":"Gounari","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2024042219003900500_bib10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2016-06-719294","article-title":"Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia","volume":"129","author":"Ahn","year":"2017","journal-title":"Blood"},{"issue":"12","key":"2024042219003900500_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1182\/bloodadvances.2016003632","article-title":"Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL","volume":"1","author":"Kadri","year":"2017","journal-title":"Blood Adv"},{"issue":"4","key":"2024042219003900500_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00277-021-04419-w","article-title":"Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort","volume":"100","author":"Bouclet","year":"2021","journal-title":"Ann Hematol"},{"issue":"6265","key":"2024042219003900500_bib13","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD(+) in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"issue":"5","key":"2024042219003900500_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood.2021011386","article-title":"Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome","volume":"139","author":"Davids","year":"2022","journal-title":"Blood"},{"issue":"4","key":"2024042219003900500_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s11864-022-00973-1","article-title":"Novel approaches for the treatment of patients with Richter\u2019s syndrome","volume":"23","author":"Iannello","year":"2022","journal-title":"Curr Treat Options Oncol"},{"issue":"13","key":"2024042219003900500_bib16","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-17-4004","article-title":"Novel Richter syndrome xenograft models to study genetic architecture, biology, and therapy responses","volume":"78","author":"Vaisitti","year":"2018","journal-title":"Cancer Res"},{"issue":"24","key":"2024042219003900500_bib17","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood.2020008404","article-title":"ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models","volume":"137","author":"Vaisitti","year":"2021","journal-title":"Blood"},{"issue":"13","key":"2024042219003900500_bib18","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.2022016211","article-title":"Anti-CD37 alpha-amanitin conjugated antibodies as potential therapeutic weapons for Richter\u2019s syndrome","volume":"140","author":"Vaisitti","year":"2022","journal-title":"Blood"},{"issue":"24","key":"2024042219003900500_bib19","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.2020010187","article-title":"Synergistic efficacy of the dual PI3K-delta\/gamma inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX models","volume":"137","author":"Iannello","year":"2021","journal-title":"Blood"},{"issue":"11","key":"2024042219003900500_bib20","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L","article-title":"Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis","volume":"32","author":"Rongvaux","year":"2002","journal-title":"Eur J Immunol"},{"issue":"2","key":"2024042219003900500_bib21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/er.2009-0026","article-title":"The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways","volume":"31","author":"Houtkooper","year":"2010","journal-title":"Endocr Rev"},{"issue":"9","key":"2024042219003900500_bib22","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3390\/cancers14092059","article-title":"Updated functional roles of NAMPT in carcinogenesis and therapeutic niches","volume":"14","author":"Lin","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7757","key":"2024042219003900500_bib23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-019-1150-2","article-title":"NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling","volume":"569","author":"Chowdhry","year":"2019","journal-title":"Nature"},{"key":"2024042219003900500_bib24","doi-asserted-by":"crossref","first-page":"172738","DOI":"10.1016\/j.ejphar.2019.172738","article-title":"High expression of NAMPT in adult T-cell leukemia\/lymphoma and anti-tumor activity of a NAMPT inhibitor","volume":"865","author":"Kozako","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"2024042219003900500_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s41375-019-0692-5","article-title":"OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis","volume":"34","author":"Korotchkina","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"2024042219003900500_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/bloodadvances.2018024182","article-title":"Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia","volume":"3","author":"Mitchell","year":"2019","journal-title":"Blood Adv"},{"issue":"5","key":"2024042219003900500_bib27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.stem.2020.07.021","article-title":"Nicotinamide metabolism mediates resistance to venetoclax in relapsed acute myeloid leukemia stem cells","volume":"27","author":"Jones","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"18","key":"2024042219003900500_bib28","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1158\/1078-0432.CCR-14-0624","article-title":"On-target effect of FK866, a nicotinamide phosphoribosyl transferase inhibitor, by apoptosis-mediated death in chronic lymphocytic leukemia cells","volume":"20","author":"Gehrke","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2024042219003900500_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/cancers14010160","article-title":"PAK4 and NAMPT as novel therapeutic targets in diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma","volume":"14","author":"Khan","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2024042219003900500_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fphar.2020.00656","article-title":"Recent advances in NAMPT inhibitors: a novel immunotherapic strategy","volume":"11","author":"Galli","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"2024042219003900500_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood-2014-07-589069","article-title":"Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia","volume":"125","author":"Audrito","year":"2015","journal-title":"Blood"},{"key":"2024042219003900500_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fonc.2020.00358","article-title":"NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation","volume":"10","author":"Audrito","year":"2020","journal-title":"Front Oncol"},{"issue":"13","key":"2024042219003900500_bib33","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","article-title":"High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation","volume":"113","author":"Burger","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2024042219003900500_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41408-022-00675-9","article-title":"Pirtobrutinib inhibits wild-type and mutant Bruton\u2019s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia","volume":"12","author":"Aslan","year":"2022","journal-title":"Blood Cancer J"},{"issue":"3","key":"2024042219003900500_bib35","doi-asserted-by":"crossref","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of drug combinations: current methodological landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"2","key":"2024042219003900500_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCRESAHA.113.300536","article-title":"Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging","volume":"114","author":"Pillai","year":"2014","journal-title":"Circ Res"},{"issue":"9","key":"2024042219003900500_bib37","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1074\/jbc.M113.537266","article-title":"Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin","volume":"289","author":"Ramakrishnan","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"13","key":"2024042219003900500_bib38","doi-asserted-by":"crossref","first-page":"110155","DOI":"10.1016\/j.celrep.2021.110155","article-title":"SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes","volume":"37","author":"Cha","year":"2021","journal-title":"Cell Rep"},{"issue":"10","key":"2024042219003900500_bib39","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1167\/iovs.19-26909","article-title":"Corneal denervation causes epithelial apoptosis through inhibiting NAD+ biosynthesis","volume":"60","author":"Li","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2024042219003900500_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bcp.2015.08.097","article-title":"FK866 compromises mitochondrial metabolism and adaptive stress responses in cultured cardiomyocytes","volume":"98","author":"Oyarzun","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"2024042219003900500_bib41","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s11357-012-9474-y","article-title":"SIRT1 inhibits apoptosis of degenerative human disc nucleus pulposus cells through activation of Akt pathway","volume":"35","author":"Wang","year":"2013","journal-title":"Age (Dordr)"},{"issue":"9","key":"2024042219003900500_bib42","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00125-021-05489-1","article-title":"M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt\/GSK-3beta\/beta-catenin pathway in mice","volume":"64","author":"Qian","year":"2021","journal-title":"Diabetologia"},{"issue":"13","key":"2024042219003900500_bib43","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1158\/0008-5472.CAN-10-4452","article-title":"Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53\/miR-34a\/SIRT1 tumor suppressor network","volume":"71","author":"Audrito","year":"2011","journal-title":"Cancer Res"},{"issue":"182","key":"2024042219003900500_bib44","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2001465","article-title":"The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy","volume":"4","author":"Sundaresan","year":"2011","journal-title":"Sci Signal"},{"issue":"6","key":"2024042219003900500_bib45","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41375-019-0683-6","article-title":"Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia","volume":"34","author":"Somers","year":"2020","journal-title":"Leukemia"},{"issue":"7","key":"2024042219003900500_bib46","first-page":"1046","article-title":"The niacin required for optimum growth can be synthesized from L-tryptophan in growing mice lacking tryptophan-2,3-dioxygenase","volume":"143","author":"Terakata","year":"2013","journal-title":"J\u00a0Nutr"},{"issue":"10","key":"2024042219003900500_bib47","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1371\/journal.pbio.0050263","article-title":"Nicotinamide riboside kinase structures reveal new pathways to NAD+","volume":"5","author":"Tempel","year":"2007","journal-title":"PLoS Biol"},{"issue":"9","key":"2024042219003900500_bib48","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbapap.2015.02.021","article-title":"Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues","volume":"1854","author":"Ruggieri","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2024042219003900500_bib49","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1038\/srep07481","article-title":"High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"issue":"34","key":"2024042219003900500_bib50","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1038\/onc.2012.407","article-title":"SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency","volume":"32","author":"Herranz","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"2024042219003900500_bib51","doi-asserted-by":"crossref","first-page":"e66283","DOI":"10.1371\/journal.pone.0066283","article-title":"Enterocyte-specific inactivation of SIRT1 reduces tumor load in the APC(+\/min) mouse model","volume":"8","author":"Leko","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"2024042219003900500_bib52","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","article-title":"Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis","volume":"119","author":"Yuan","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2024042219003900500_bib53","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/cncr.25676","article-title":"Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer","volume":"117","author":"Alhazzazi","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"2024042219003900500_bib54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2024042219003900500_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2013-11-538819","article-title":"SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia","volume":"124","author":"Sasca","year":"2014","journal-title":"Blood"},{"issue":"10","key":"2024042219003900500_bib56","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/PAS.0b013e31816b6478","article-title":"SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma","volume":"32","author":"Jang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"2024042219003900500_bib57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12935-018-0659-z","article-title":"SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population","volume":"18","author":"Kan","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"22","key":"2024042219003900500_bib58","doi-asserted-by":"crossref","first-page":"19102","DOI":"10.18632\/oncotarget.3905","article-title":"The SIRT1\/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells","volume":"6","author":"Dal Bo","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"2024042219003900500_bib59","doi-asserted-by":"crossref","first-page":"e22739","DOI":"10.1371\/journal.pone.0022739","article-title":"Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells","volume":"6","author":"Cea","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"2024042219003900500_bib60","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1158\/0008-5472.CAN-05-3617","article-title":"Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes","volume":"66","author":"Heltweg","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"2024042219003900500_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.onc.1209049","article-title":"Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells","volume":"25","author":"Ota","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"2024042219003900500_bib62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.06.045","article-title":"A\u00a0role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells","volume":"373","author":"Kojima","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2024042219003900500_bib63","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ccell.2016.04.005","article-title":"A\u00a0SIRT2-selective inhibitor promotes c-Myc oncoprotein degradation and exhibits broad anticancer activity","volume":"29","author":"Jing","year":"2016","journal-title":"Cancer Cell"},{"key":"2024042219003900500_bib64","doi-asserted-by":"crossref","first-page":"752117","DOI":"10.3389\/fphys.2021.752117","article-title":"Human sirtuin regulators: the \u201cSuccess\u201d stories","volume":"12","author":"Curry","year":"2021","journal-title":"Front Physiol"},{"issue":"3","key":"2024042219003900500_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic potential of NAD-boosting molecules: the in\u00a0vivo evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab"},{"issue":"4","key":"2024042219003900500_bib66","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1073\/pnas.1105304109","article-title":"The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop","volume":"109","author":"Menssen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"2024042219003900500_bib67","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biocel.2011.07.006","article-title":"Sirt1 deacetylates c-Myc and promotes c-Myc\/Max association","volume":"43","author":"Mao","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"2024042219003900500_bib68","doi-asserted-by":"crossref","first-page":"e1002135","DOI":"10.1371\/journal.pgen.1002135","article-title":"SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability","volume":"7","author":"Marshall","year":"2011","journal-title":"PLoS Genet"},{"issue":"3","key":"2024042219003900500_bib69","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/cdd.2012.147","article-title":"The histone deacetylase SIRT2 stabilizes Myc oncoproteins","volume":"20","author":"Liu","year":"2013","journal-title":"Cell Death Differ"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/8\/1920\/2222887\/blooda_adv-2023-011690-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/8\/1920\/2222887\/blooda_adv-2023-011690-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T19:01:00Z","timestamp":1713812460000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/8\/1920\/514976\/A-molecular-circuit-linking-the-BCR-to-the-NAD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011690","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]}}}